Trump Claims Pardon for Tina Peters Despite No Legal Authority 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
South Korea Warns Weak Won Could Push Inflation Higher in 2025 
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores 
Special Prosecutor Alleges Yoon Suk Yeol Sought North Korea Provocation to Justify Martial Law 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute 
Gold and Silver Surge as Safe Haven Demand Rises on U.S. Economic Uncertainty 
Asian Currencies Trade Sideways as Dollar Weakens Ahead of Key U.S. Data 
Chinese Robotaxi Stocks Rally as Tesla Boosts Autonomous Driving Optimism 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Wall Street Futures Slip as Tech Stocks Struggle Ahead of Key US Economic Data 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 
Oil Prices Rebound as U.S.-Venezuela Tensions Offset Oversupply Concerns 
Johnson & Johnson (J&J) has sued drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, and at least $25 million in damages from each defendant.
Patients complaining about receiving the wrong pills in their prescription bottles led J&J to discover widespread counterfeiting, as did the voluntary return of hundreds of bottles of counterfeit pharmaceuticals from one of the defendants, distributor ProPharma Distribution LLC.
Following Gilead Sciences Inc.'s lawsuit in January, the firm said it became aware of the sale of counterfeit versions of its HIV medications. Symtuza, a multi-drug combination treatment, as well as Prezcobix, Prezista, and Edurant, are among the medications at issue.
J&J claims that counterfeit bottles occasionally included a different HIV medicine than what was advertised on the label and that one counterfeit bottle contained the strong antipsychotic Seroquel.
The defendants include ProPharma, Safe Chain Solutions LLC, and Scripts Wholesale Inc, as well as drugstore operator I Care Pharmacy 14 and the business' individual proprietors.
According to the lawsuit, I Care Pharmacy had a physical location in New York City that was closed down immediately after a fraudulent transaction was found.
J&J believes the pharmacy is linked to a criminal counterfeiting network that is still operational in New York City, dispensing hazardous counterfeit HIV medication.
